Strides Pharma Science Limited (Strides or Company), a global pharmaceutical company today announced that it has developed and commercialized Favipiravir Antiviral tablets. The product is a generic version of Avigan® of Toyama Chemical, Japan. Favipiravir is an antiviral medication that was initially developed to treat influenza in Japan.
source https://www.pharmatutor.org/pharma-news/2020/strides-develops-and-commences-export-of-favipiravir-antiviral-tablets
No comments:
Post a Comment